Search filters

List of works by Pelin Mutlu

An update on molecular biology and drug resistance mechanisms of multiple myeloma

scientific article published on 16 July 2015

Association between XRCC3 Thr241Met polymorphism and laryngeal cancer susceptibility in Turkish population.

scientific article published on 16 December 2014

Association of -174G/C interleukin/6 gene polymorphism with the risk of chronic lymphocytic, chronic myelogenous and acute myelogenous leukemias in Turkish patients

scientific article published on 01 July 2014

Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy.

scientific article

Co-delivery of Doxorubicin and D-α-Tocopherol polyethylene glycol 1000 succinate by Magnetic Nanoparticles

scientific article published on 13 March 2018

Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations

scientific article published on 01 March 2015

Determination of the relationship between doxorubicin resistance and Wnt signaling pathway in HeLa and K562 cell lines.

scientific article published on 2 May 2018

Different types of cell cycle- and apoptosis-related gene expressions alter in corticosteroid-, vincristine-, and melphalan-resistant u-266 multiple myeloma cell lines

scientific article published on September 2014

Differential gene expression analysis related to extracellular matrix components in drug-resistant RPMI-8226 cell line

scientific article published on February 28, 2012

Differential oncogene-related gene expressions in myeloma cells resistant to prednisone and vincristine

scientific article published on May 9, 2012

Effect of cobalt-60 (γ radiation) on multidrug-resistant multiple myeloma cell lines

scientific article published on July 2011

Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery

scientific article published on 07 October 2016

Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer

scientific article published on July 2014

Identification of XRCC1 Arg399Gln and XRCC3 Thr241Met Polymorphisms in a Turkish Population and Their Association with the Risk of Chronic Lymphocytic Leukemia

scientific article published on 11 December 2014

Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug.

scientific article published on 12 May 2016

Polyhydroxybutyrate-coated magnetic nanoparticles for doxorubicin delivery: cytotoxic effect against doxorubicin-resistant breast cancer cell line

scientific article published on November 2014

Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.

scientific article

The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients

scientific article published on 21 May 2014